Lupin launches ipratropium bromide nasal spray in US market

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children aged 6 years and older. Shares of Lupin Ltd ended at ₹1,982.20, up by ₹26.60, or 1.36%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *